Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Pharmacol Exp Ther
2008 Dec 01;3273:884-90. doi: 10.1124/jpet.108.144758.
Show Gene links
Show Anatomy links
Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide.
Gay EA
,
Klein RC
,
Melton MA
,
Blackshear PJ
,
Yakel JL
.
???displayArticle.abstract???
A variety of peptide ligands are known to inhibit the function of neuronal nicotinic acetylcholine receptors (nAChRs), including small toxins and brain-derived peptides such as beta-amyloid(1-42) and synthetic apolipoproteinE peptides. The myristoylated alanine-rich C kinase substrate (MARCKS) protein is a major substrate of protein kinase C and is highly expressed in the developing and adult brain. The ability of a 25-amino acid synthetic MARCKS peptide, derived from the effector domain (ED), to modulate nAChR activity was tested. To determine the effects of the MARCKS ED peptide on nAChR function, receptors were expressed in Xenopus laevis oocytes, and two-electrode voltage-clamp experiments were performed. The MARCKS ED peptide completely inhibited acetylcholine (ACh)-evoked responses from alpha7 nAChRs in a dose-dependent manner, yielding an IC(50) value of 16 nM. Inhibition of ACh-induced responses was both activity- and voltage-independent. The MARCKS ED peptide was unable to block alpha-bungarotoxin binding. A MARCKS ED peptide in which four serine residues were replaced with aspartate residues was unable to inhibit alpha7 nAChR-mediated currents. The MARCKS ED peptide inhibited ACh-induced alpha4beta2 and alpha2beta2 responses, although with decreased potency. The effects of the MARCKS ED peptide on native nAChRs were tested using acutely isolated rat hippocampal slices. In hippocampal interneurons, the MARCKS ED peptide was able to block native alpha7 nAChRs in a dose-dependent manner. The MARCKS ED peptide represents a novel antagonist of neuronal nAChRs that has considerable utility as a research tool.
Aderem,
The MARCKS brothers: a family of protein kinase C substrates.
1992, Pubmed
Aderem,
The MARCKS brothers: a family of protein kinase C substrates.
1992,
Pubmed
Arbuzova,
Cross-talk unfolded: MARCKS proteins.
2002,
Pubmed
Arneric,
Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.
2007,
Pubmed
Blackshear,
The MARCKS family of cellular protein kinase C substrates.
1993,
Pubmed
Calabrese,
Essential role for the PKC target MARCKS in maintaining dendritic spine morphology.
2005,
Pubmed
Colquhoun,
Activation of ion channels in the frog end-plate by high concentrations of acetylcholine.
1988,
Pubmed
Di Angelantonio,
Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.
2003,
Pubmed
Di Angelantonio,
A novel class of peptides with facilitating action on neuronal nicotinic receptors of rat chromaffin cells in vitro: functional and molecular dynamics studies.
2002,
Pubmed
Dineley,
beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes.
2002,
Pubmed
,
Xenbase
Dougherty,
Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex.
2003,
Pubmed
Dwoskin,
Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.
2001,
Pubmed
Gay,
Apolipoprotein E-derived peptides block alpha7 neuronal nicotinic acetylcholine receptors expressed in xenopus oocytes.
2006,
Pubmed
,
Xenbase
Graff,
Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C.
1989,
Pubmed
Graff,
Protein kinase C substrate and inhibitor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain.
1991,
Pubmed
Grassi,
Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.
2003,
Pubmed
,
Xenbase
Greenfield,
A novel peptide modulates alpha7 nicotinic receptor responses: implications for a possible trophic-toxic mechanism within the brain.
2004,
Pubmed
,
Xenbase
Hussain,
Myristoylated alanine rich C kinase substrate (MARCKS) heterozygous mutant mice exhibit deficits in hippocampal mossy fiber-CA3 long-term potentiation.
2006,
Pubmed
Khiroug,
Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons.
2003,
Pubmed
Klein,
Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices.
2004,
Pubmed
Lamb,
Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide.
2005,
Pubmed
,
Xenbase
Li,
Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
2006,
Pubmed
Liu,
beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons.
2001,
Pubmed
Lukas,
Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.
2001,
Pubmed
Lynch,
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury.
2005,
Pubmed
Maconochie,
Markov modelling of ensemble current relaxations: bovine adrenal nicotinic receptor currents analysed.
1992,
Pubmed
McAdoo,
Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury.
2005,
Pubmed
McNamara,
Effect of myristoylated alanine-rich C kinase substrate (MARCKS) overexpression on hippocampus-dependent learning and hippocampal synaptic plasticity in MARCKS transgenic mice.
2005,
Pubmed
McNamara,
Effect of reduced myristoylated alanine-rich C kinase substrate expression on hippocampal mossy fiber development and spatial learning in mutant mice: transgenic rescue and interactions with gene background.
1998,
Pubmed
Ouimet,
Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain.
1990,
Pubmed
Pettit,
beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.
2001,
Pubmed
Spizz,
Protein kinase C-mediated phosphorylation of the myristoylated alanine-rich C-kinase substrate protects it from specific proteolytic cleavage.
1996,
Pubmed
Spizz,
Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme.
1997,
Pubmed
Stumpo,
MARCKS deficiency in mice leads to abnormal brain development and perinatal death.
1995,
Pubmed
Sudweeks,
Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons.
2000,
Pubmed
Sundaram,
The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components.
2004,
Pubmed
Wu,
beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells.
2004,
Pubmed
Yamauchi,
Crystal structure of a MARCKS peptide containing the calmodulin-binding domain in complex with Ca2+-calmodulin.
2003,
Pubmed
